Cargando…

Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature

BACKGROUND: The management of metastatic Renal Cell Carcinoma (RCC) has changed dramatically in the last 20 years, and the role of surgery in the immunotherapy’s era is under debate. Metastatic lesions interesting pancreas are infrequent, but those harbouring from RCC have an high incidence. If meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Boni, Andrea, Cochetti, Giovanni, Ascani, Stefano, Del Zingaro, Michele, Quadrini, Francesca, Paladini, Alessio, Cocca, Diego, Mearini, Ettore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998557/
https://www.ncbi.nlm.nih.gov/pubmed/29895293
http://dx.doi.org/10.1186/s12893-018-0371-x
_version_ 1783331252409991168
author Boni, Andrea
Cochetti, Giovanni
Ascani, Stefano
Del Zingaro, Michele
Quadrini, Francesca
Paladini, Alessio
Cocca, Diego
Mearini, Ettore
author_facet Boni, Andrea
Cochetti, Giovanni
Ascani, Stefano
Del Zingaro, Michele
Quadrini, Francesca
Paladini, Alessio
Cocca, Diego
Mearini, Ettore
author_sort Boni, Andrea
collection PubMed
description BACKGROUND: The management of metastatic Renal Cell Carcinoma (RCC) has changed dramatically in the last 20 years, and the role of surgery in the immunotherapy’s era is under debate. Metastatic lesions interesting pancreas are infrequent, but those harbouring from RCC have an high incidence. If metachronous resections are not rare, synchronous resection of primary RCC and its pancreatic metastasis is uncommonly reported, and accounts for a bad prognosis. CASE PRESENTATION: We report the case of a 68 years old woman, who presented hematuria at hospital incoming, with radiological appearance of a 13 cm left renal mass, with a 2.5 cm single pancreatic tail metastasis. Work-up of staging ruled out other distant metastases, urothelial cancer and there was no evidence of inferior vena cava thrombosis. We choose a 5-port trans-peritoneal robotic approach using lazy right lateral decubitus. Synchronous robotic radical nephrectomy and spleen-sparing pancreatic resection was performed. The pancreatic mass was completely enucleated from pancreatic parenchyma using a latero-medial dissection. Peri-operative hemoglobine loss was 2.4 g/dL. Total operative time was 213 min. No post-operative complications were recorded and patient was discharged in 7th post-operative day. Histopathological examination showed a pT2b N0 M1 RCC, Fuhrman grade II, with pancreatic tail metastasis; both, primary and metastatic lesions had the same histological characteristics with negative surgical margins. After 9 months patient had no evidence of disease recurrence at radiological studies. CONCLUSIONS: The rationale for surgical removal of disseminated tumor, followed by immunotherapy, includes improving prognosis and enhancing the potential of an immune-mediated response to systemic treatment. A spleen-sparing procedure can adequately preserve post-operative immunologic capabilities. In our experience, the correct assessment of pre-operative imaging data and surgeon skills in robotic surgery seem to play a key role in the success of these procedures. Robotic surgery seems to enhance the possibility to control multiple vessels encountered during dissection. Such a conservative approach may be helpful in future research aimed at uncovering biological features, and also leading to better targeted preventive interventions and more individualized and effective treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12893-018-0371-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5998557
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59985572018-06-25 Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature Boni, Andrea Cochetti, Giovanni Ascani, Stefano Del Zingaro, Michele Quadrini, Francesca Paladini, Alessio Cocca, Diego Mearini, Ettore BMC Surg Case Report BACKGROUND: The management of metastatic Renal Cell Carcinoma (RCC) has changed dramatically in the last 20 years, and the role of surgery in the immunotherapy’s era is under debate. Metastatic lesions interesting pancreas are infrequent, but those harbouring from RCC have an high incidence. If metachronous resections are not rare, synchronous resection of primary RCC and its pancreatic metastasis is uncommonly reported, and accounts for a bad prognosis. CASE PRESENTATION: We report the case of a 68 years old woman, who presented hematuria at hospital incoming, with radiological appearance of a 13 cm left renal mass, with a 2.5 cm single pancreatic tail metastasis. Work-up of staging ruled out other distant metastases, urothelial cancer and there was no evidence of inferior vena cava thrombosis. We choose a 5-port trans-peritoneal robotic approach using lazy right lateral decubitus. Synchronous robotic radical nephrectomy and spleen-sparing pancreatic resection was performed. The pancreatic mass was completely enucleated from pancreatic parenchyma using a latero-medial dissection. Peri-operative hemoglobine loss was 2.4 g/dL. Total operative time was 213 min. No post-operative complications were recorded and patient was discharged in 7th post-operative day. Histopathological examination showed a pT2b N0 M1 RCC, Fuhrman grade II, with pancreatic tail metastasis; both, primary and metastatic lesions had the same histological characteristics with negative surgical margins. After 9 months patient had no evidence of disease recurrence at radiological studies. CONCLUSIONS: The rationale for surgical removal of disseminated tumor, followed by immunotherapy, includes improving prognosis and enhancing the potential of an immune-mediated response to systemic treatment. A spleen-sparing procedure can adequately preserve post-operative immunologic capabilities. In our experience, the correct assessment of pre-operative imaging data and surgeon skills in robotic surgery seem to play a key role in the success of these procedures. Robotic surgery seems to enhance the possibility to control multiple vessels encountered during dissection. Such a conservative approach may be helpful in future research aimed at uncovering biological features, and also leading to better targeted preventive interventions and more individualized and effective treatments. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12893-018-0371-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-13 /pmc/articles/PMC5998557/ /pubmed/29895293 http://dx.doi.org/10.1186/s12893-018-0371-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Boni, Andrea
Cochetti, Giovanni
Ascani, Stefano
Del Zingaro, Michele
Quadrini, Francesca
Paladini, Alessio
Cocca, Diego
Mearini, Ettore
Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title_full Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title_fullStr Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title_full_unstemmed Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title_short Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
title_sort robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998557/
https://www.ncbi.nlm.nih.gov/pubmed/29895293
http://dx.doi.org/10.1186/s12893-018-0371-x
work_keys_str_mv AT boniandrea robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT cochettigiovanni robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT ascanistefano robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT delzingaromichele robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT quadrinifrancesca robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT paladinialessio robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT coccadiego robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature
AT meariniettore robotictreatmentofoligometastatickidneytumorwithsynchronouspancreaticmetastasiscasereportandreviewoftheliterature